Novartis Investigative Site

La Victoria, Lima region 13

0 studies enrolling now · 2 studies all time

What they study most

Ankylosing Spondylitis, Spondylitis, Ankylosing

Studies at this site

• Extension in AS: Sustainability of Benefits, Safety and Tolerability — Completed
• 16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis — Completed